We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
+18.69%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+505.55%
AUM
$389B
AUM Growth
+$36.3B
Cap. Flow
-$17.4B
Cap. Flow %
-4.48%
Top 10 Hldgs %
19.75%
Holding
5,916
New
643
Increased
1,905
Reduced
2,520
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 14.23%
2 Consumer Discretionary 8.46%
3 Healthcare 7.67%
4 Financials 7.46%
5 Communication Services 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NINE
5326
DELISTED
Nine Energy Service
NINE
$38K ﹤0.01%
+14,154
New +$26K
PTN
5327
Palatin Technologies
PTN
$14.1M
$38K ﹤0.01%
45
TTI icon
5328
TETRA Technologies
TTI
$1.25B
$37K ﹤0.01%
42,750
-22,955
-35% -$15.7K
STRDW
5329
DELISTED
Sitio Royalties Corp. Warrant
STRDW
$36K ﹤0.01%
250,000
RNTX
5330
Rein Therapeutics
RNTX
$61.1M
$35K ﹤0.01%
+1,660
New +$41.5K
PHAS
5331
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$35K ﹤0.01%
10,479
-3,427
-25% -$12.3K
ATXS
5332
DELISTED
Astria Therapeutics
ATXS
$34K ﹤0.01%
2,666
-2,444
-48% -$43.6K
DXYN
5333
DELISTED
Dixie Group Inc
DXYN
$33K ﹤0.01%
+12,794
New +$21.7K
HOFVW
5334
DELISTED
Hall of Fame Resort & Entertainment Company Warrant
HOFVW
$32K ﹤0.01%
122,980
VEON icon
5335
VEON
VEON
$3.78B
$30K ﹤0.01%
803
-2,778
-78% -$98.9K
ALNA
5336
DELISTED
Allena Pharmaceuticals
ALNA
$30K ﹤0.01%
23,339
-55,595
-70% -$77.5K
IBIO icon
5337
iBio
IBIO
$69.5M
$29K ﹤0.01%
54
+29
+116% +$23.6K
REI icon
5338
Ring Energy
REI
$312M
$29K ﹤0.01%
43,991
-14,877
-25% -$9.8K
TLSA icon
5339
Tiziana Life Sciences
TLSA
$126M
$29K ﹤0.01%
+14,566
New +$46K
AGFS
5340
DELISTED
AgroFresh Solutions Inc
AGFS
$29K ﹤0.01%
12,837
-980
-7% -$2.31K
USWS
5341
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$29K ﹤0.01%
3,280
ASRT
5342
DELISTED
Assertio
ASRT
$26K ﹤0.01%
1,190
-63
-5% -$1.96K
HYMCZ
5343
DELISTED
Hycroft Mining Holding Corporation Warrant
HYMCZ
$26K ﹤0.01%
71,594
-14,225
-17% -$4.31K
DWSN icon
5344
Dawson Geophysical
DWSN
$138M
$23K ﹤0.01%
10,897
-4
-0% -$8
TOON icon
5345
Kartoon Studios
TOON
$35.1M
$23K ﹤0.01%
+1,693
New +$22.9K
YJ
5346
Yunji
YJ
$6.3M
$22K ﹤0.01%
+303
New +$26.3K
MITO
5347
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$22K ﹤0.01%
+14,989
New +$21K
OCGN icon
5348
Ocugen
OCGN
$434M
$21K ﹤0.01%
+11,258
New +$5.42K
APSG.WS
5349
DELISTED
Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer
APSG.WS
$21K ﹤0.01%
+11,280
New +$17.7K
AMPE
5350
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$19K ﹤0.01%
+41
New +$13.4K

Similar funds

Goldman Sachs's Q4 2020 Portfolio in Review

As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.

  • Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
  • Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
  • Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
  • Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
  • Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
  • Goldman Sachs opened 643 new positions and closed 466 in Q4 2020.
  • Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.

Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.